CeriBell, Inc.

CBLL · NasdaqGS · Stock · Healthcare
$26.37
+0.88% today
Delayed price,

What CeriBell does

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Key facts

Sector
Healthcare
Industry
Medical Devices
Market cap
$1.01B
P/E (ttm)
—
Forward P/E
-16.3
Dividend yield
0.00%
Beta
0.93
Profit margin
-64.7%
Employees
327
Headquarters
Sunnyvale, CA, United States
Exchange
NasdaqGS

Performance

1 Month
+8.2%
3 Months
+40.9%
6 Months
+24.4%
1 Year
+107.5%
5 Years
-8.4%
$10.8552-week range$26.72
Biggest setback — last 12 months
-30.1%
5 Jan 2026 → 11 May 2026
Fell from $23.33 to $16.30 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+131.3%
27 Oct 2025 → 12 Oct 2026
Ran from $11.40 to $26.37 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▲ Trend: Uptrend
Price is above its 20-, 50- and 200-day averages, each stacked above the next — a classic technical uptrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$22.88 (-13.2%)$26.37$30.39 (+15.3%)
3 Months$20.62 (-21.8%)$26.37$33.72 (+27.9%)
6 Months$18.63 (-29.4%)$26.37$37.33 (+41.6%)
12 Months$16.13 (-38.8%)$26.37$43.12 (+63.5%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 49.2%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 9,774 shares at $24.38 — Woo Raymond, Chief Technology Officer · 2026-10-02
Sold 20,846 shares at $25.03 — Chao Xingjuan, President and CEO · 2026-09-17
Sold 1,692 shares at $25.00 — Blumberg Scott, Chief Financial Officer · 2026-09-17
Sold 16,755 shares at $24.25 — Foehr David, Senior VP, Finance and PAO · 2026-09-10
Sold 18,163 shares at $24.33 — Woo Raymond, Chief Technology Officer · 2026-09-10
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.